Loading provider…
Loading provider…
Hematology & Oncology Physician in Pismo Beach, CA
NPI: 1396815965Primary Practice Location
Coastal Surgical Institute
921 Oak Park Blvd, Pismo Beach, CA
Primary Employer
Oncology Physicians Network of California PC
ccare.com
HQ Phone
Get M.D. David's Phone Numberphone_androidMobile
Get M.D. David's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1987 - 2026

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Medical Oncology
University of California (San Diego) Medical Center
Fellowship • Hematology and Medical Oncology
1989 - 1990
Santa Barbara Cottage Hospital
Residency • Internal Medicine
1986 - 1989
Saint Louis University School Of Medicine
slu.edu
Medical School
Until 1986
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 313 | 1,052 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 76 | 98 |
| 3 | 99442Physician telephone patient service, 11-20 minutes of medical discussion | 65 | 157 |
| 4 | 99212Established patient outpatient visit, total time 10-19 minutes | 59 | 211 |
| 5 | 99211Established patient office or other outpatient visit, typically 5 minutes | 47 | 188 |
Authors: Eric Small
Journal: J Clin Oncol
Quality of life impact of three different doses of suramin in patients with metastatic hormone-refractory prostate carcinoma : Results of intergroup 0159/cancer and le...
Authors: Tim A. Ahles, James E. Herndon, Eric J. Small, N. J. Vogelzang, Alice B. Kornblith
Randomized study of three different doses of suramin administered with a fixed dosing schedule in patients with advanced prostate cancer: results of intergroup 0159, c...
Authors: Eric J. Small, Susan Halabi, Mark J. Ratain, Gary L. Rosner, Walter M. Stadler
Lead Sponsor: Academic and Community Cancer Research United
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Placebo, OTHER: Questionnaire Administration, OTHER: Quality-of-Life Assessment, DRUG: Minocycline Hydrochloride
Lead Sponsor: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: Letrozole, DRUG: Ribociclib, DRUG: Leuprolide, DRUG: Goserelin
Lead Sponsor: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: LEE011